These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 923110
1. [Antihypertensive effects of coenzyme Q10 in essential hypertension--in relation to the renin-aldosterone system]. Hata S, Kunida H, Oyama Y. Horumon To Rinsho; 1977 Sep; 25(9):1019-23. PubMed ID: 923110 [No Abstract] [Full Text] [Related]
2. [Antihypertensive effect of carteolol, a beta-receptor blockader, in essential hypertension and its action on the renin-aldosterone system]. Hata S, Kunita H. Horumon To Rinsho; 1977 Aug; 25(8):907-15. PubMed ID: 334398 [No Abstract] [Full Text] [Related]
3. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients. Semplicini A, Strapazzon G, Papparella I, Sartori M, Realdi A, Macchini L, Calò LA, Ceolotto G. J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904 [Abstract] [Full Text] [Related]
4. [Antihypertensive effects of ecarazine hydrochloride in essential hypertension and its action on the renin-aldosterone system]. Hata S, Yoshioka M, Kunida H. Horumon To Rinsho; 1976 Sep; 24(9):919-34. PubMed ID: 795573 [No Abstract] [Full Text] [Related]
5. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Mahmud A, Mahgoub M, Hall M, Feely J. Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838 [Abstract] [Full Text] [Related]
6. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. Lamarre-Cliche M, de Champlain J, Lacourcière Y, Poirier L, Karas M, Larochelle P. Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618 [Abstract] [Full Text] [Related]
7. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine. Niizuma S, Nakahama H, Kamide K, Fukuchi K, Iwanaga Y, Nakata H, Yoshihara F, Horio T, Nakamura S, Kawano Y. Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267 [Abstract] [Full Text] [Related]
8. Coenzyme Q10 in essential hypertension. Digiesi V, Cantini F, Oradei A, Bisi G, Guarino GC, Brocchi A, Bellandi F, Mancini M, Littarru GP. Mol Aspects Med; 1994 Oct; 15 Suppl():s257-63. PubMed ID: 7752838 [Abstract] [Full Text] [Related]
9. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension. Hannila-Handelberg T, Kontula KK, Paukku K, Lehtonen JY, Virtamo J, Tikkanen I, Hiltunen TP. J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122 [Abstract] [Full Text] [Related]
11. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension. Mizuno K, Hashimoto S, Yabe R, Kunii N, Niimura S, Tani M, Watari H, Fukuchi S. Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729 [Abstract] [Full Text] [Related]
12. [SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension]. Werning C, Stiel D, Hammann K, Schweikert HU, Fischer N, Siegenthaler W. Fortschr Med; 1972 Jul 20; 90(20):785-7. PubMed ID: 5074231 [No Abstract] [Full Text] [Related]
13. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy]. Nast HP, Philipp T. Fortschr Med; 1974 Apr 18; 92(11):447-51. PubMed ID: 4362672 [No Abstract] [Full Text] [Related]
14. Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension. Cugini P, Serdoz R, Manconi R, Mancini A, Meucci T. Boll Soc Ital Biol Sper; 1978 Jan 30; 54(2):111-5. PubMed ID: 737057 [No Abstract] [Full Text] [Related]
15. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program. Bühler FR, Lütold BE. Adv Nephrol Necker Hosp; 1976 Jan 30; 6():303-17. PubMed ID: 14485 [Abstract] [Full Text] [Related]
16. Aldosterone and refractory hypertension: a prospective cohort study. Sartori M, Calò LA, Mascagna V, Realdi A, Macchini L, Ciccariello L, De Toni R, Cattelan F, Pessina AC, Semplicini A. Am J Hypertens; 2006 Apr 30; 19(4):373-9; discussion 380. PubMed ID: 16580572 [Abstract] [Full Text] [Related]
17. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension. Doi SA, Abalkhail S, Al-Qudhaiby MM, Al-Humood K, Hafez MF, Al-Shoumer KA. J Hum Hypertens; 2006 Jul 30; 20(7):482-9. PubMed ID: 16617310 [Abstract] [Full Text] [Related]
18. Tagging SNPs in REN, AGTR1 and AGTR2 genes and response of renin activity, angiotensin II and aldosterone concentrations to antihypertensive treatment in Kazakans. Yan W, Zhang Y, Shan Z, Wang Q, Huang Y, Wang C, Yan K. J Renin Angiotensin Aldosterone Syst; 2011 Dec 30; 12(4):581-7. PubMed ID: 21810897 [Abstract] [Full Text] [Related]
19. Antihypertensive treatment and plasma renin activity in essential hypertension. Chen WY, Hsieh BS, Yen TS, Cheng JT, Yang SM. Taiwan Yi Xue Hui Za Zhi; 1976 Dec 30; 75(12):665-73. PubMed ID: 1071754 [No Abstract] [Full Text] [Related]
20. [Usefulness of coenzyme Q10 in the treatment of hypertension]. Drzewoski J, Folkers K, Richardson PC, Shizukuishi S, Baker LE. Pol Tyg Lek; 1981 Jul 06; 36(27):997-1001. PubMed ID: 7301653 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]